Outremont, Canada

William D Lubell

This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Universitéde Montreal, Bar-Ilan University, Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines S.e.c.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William D Lubell. Retrieved from https://idiyas.com/inventor/william-d-lubell-us48vdyp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.5

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of William D. Lubell

Introduction

William D. Lubell is a notable inventor based in Outremont, Canada. He has made significant contributions to the field of cyclic peptides, particularly with his innovative work on GHRP-6 analogs. His research focuses on the modulation of CD36 activity, which has implications for treating various diseases.

Latest Patents

William D. Lubell holds a patent for "Cyclic peptides and uses thereof." This patent describes novel cyclic peptide GHRP-6 analogs that can be utilized for modulating CD36 activity. These analogs may be beneficial in treating CD36-related diseases, disorders, or conditions, such as atherosclerosis and age-related macular degeneration.

Career Highlights

Lubell is affiliated with the Université de Montréal, where he continues to advance his research in peptide chemistry. His work has garnered attention for its potential applications in medical treatments and therapeutic interventions.

Collaborations

Some of his notable coworkers include Huy Ong and Jinqiang Zhang, who have collaborated with him on various research projects.

Conclusion

William D. Lubell's contributions to the field of cyclic peptides highlight his innovative spirit and dedication to advancing medical science. His work has the potential to impact the treatment of significant health conditions, showcasing the importance of research and innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…